Out-of-Hospital Mortality Among Patients Receiving Methadone for Noncancer Pain

Authors:

Abstract
Methadone hydrochloride, a μ-opioid agonist long used as evidence-based treatment for opioid dependence,1 has been increasingly prescribed for chronic pain. In 2009, 4.4 million methadone prescriptions in the United States were for treatment of pain, accounting for 9% of prescribed opioid analgesics on a dose-adjusted basis.1 Methadone's efficacy is comparable to that of other long-acting opioids2; however, its primary advantages as an analgesic are a long elimination half-life3 and low cost.1

This publication has 39 references indexed in Scilit: